Esam E. El-Fakahany - Publications

Affiliations: 
Neuroscience University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Neuroscience Biology, Pharmacology

183 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Jakubik J, El-Fakahany EE. Allosteric modulation of muscarinic receptors Neuromethods. 107: 95-130. DOI: 10.1007/978-1-4939-2858-3_6  0.84
2016 El-Fakahany EE, Jakubik J. Radioligand binding at muscarinic receptors Neuromethods. 107: 37-68. DOI: 10.1007/978-1-4939-2858-3_3  0.84
2016 Alquicer G, Doležal V, El-Fakahany EE. Utilization of superfused cerebral slices in probing muscarinic receptor autoregulation of acetylcholine release Neuromethods. 107: 221-233. DOI: 10.1007/978-1-4939-2858-3_12  0.84
2015 Janickova H, Rudajev V, Dolejsi E, Koivisto H, Jakubik J, Tanila H, El-Fakahany EE, Dolezal V. Lipid-Based Diets Improve Muscarinic Neurotransmission in the Hippocampus of Transgenic APPswe/PS1dE9 Mice. Current Alzheimer Research. 12: 923-31. PMID 26502816  0.84
2015 Jakubík J, El-Fakahany EE, Doležal V. Towards predictive docking at aminergic G-protein coupled receptors. Journal of Molecular Modeling. 21: 284. PMID 26453085 DOI: 10.1007/s00894-015-2824-9  0.84
2015 Randáková A, Dolejší E, Rudajev V, Zimčík P, Doležal V, El-Fakahany EE, Jakubík J. Classical and atypical agonists activate M1 muscarinic acetylcholine receptors through common mechanisms. Pharmacological Research. 97: 27-39. PMID 25882246 DOI: 10.1016/j.phrs.2015.04.002  0.84
2015 Michal P, El-Fakahany EE, Doležal V. Changes in Membrane Cholesterol Differentially Influence Preferential and Non-preferential Signaling of the M1 and M3 Muscarinic Acetylcholine Receptors. Neurochemical Research. 40: 2068-77. PMID 24821386 DOI: 10.1007/s11064-014-1325-z  0.84
2014 Jakubík J, Zimčík P, Randáková A, Fuksová K, El-Fakahany EE, Doležal V. Molecular mechanisms of methoctramine binding and selectivity at muscarinic acetylcholine receptors. Molecular Pharmacology. 86: 180-92. PMID 24870405 DOI: 10.1124/mol.114.093310  0.84
2014 Jakubík J, Šantrůcková E, Randáková A, Janíčková H, Zimčík P, Rudajev V, Michal P, El-Fakahany EE, Doležal V. Outline of therapeutic interventions with muscarinic receptor-mediated transmission Physiological Research. 63: S177-S189. PMID 24564657  0.84
2014 Šantrůčková E, Doležal V, El-Fakahany EE, Jakubík J. Long-term activation upon brief exposure to xanomleline is unique to M1 and M4 subtypes of muscarinic acetylcholine receptors. Plos One. 9: e88910. PMID 24558448 DOI: 10.1371/journal.pone.0088910  0.84
2013 Janíčková H, Rudajev V, Zimčík P, Jakubík J, Tanila H, El-Fakahany EE, Doležal V. Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β(1-42). Neuropharmacology. 67: 272-83. PMID 23206502 DOI: 10.1016/j.neuropharm.2012.11.014  0.84
2011 Jakubík J, Janíčková H, Randáková A, El-Fakahany EE, Doležal V. Subtype differences in pre-coupling of muscarinic acetylcholine receptors. Plos One. 6: e27732. PMID 22110745 DOI: 10.1371/journal.pone.0027732  0.84
2011 Jakubík J, Janíčková H, El-Fakahany EE, Doležal V. Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacy British Journal of Pharmacology. 162: 1029-1044. PMID 20958290 DOI: 10.1111/j.1476-5381.2010.01081.x  0.84
2010 Grant MK, Noetzel MJ, De Lorme KC, Jakubík J, Doležal V, El-Fakahany EE. Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor. Plos One. 5: e15722. PMID 21203415 DOI: 10.1371/journal.pone.0015722  0.84
2010 Jakubík J, El-Fakahany EE. Allosteric modulation of muscarinic acetylcholine receptors Pharmaceuticals. 3: 2838-2860. DOI: 10.3390/ph3092838  0.84
2009 Jakubík J, Randáková A, El-Fakahany EE, Dolezal V. Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors. Bmc Pharmacology. 9: 15. PMID 20038295 DOI: 10.1186/1471-2210-9-15  0.84
2009 Cabadak H, Cuadra AE, El-Fakahany EE, Kan B. M2, M3, and M4 muscarinic receptors are expressed in the guinea pig gallbladder. Journal of Receptor and Signal Transduction Research. 29: 63-6. PMID 19519171 DOI: 10.1080/10799890802687416  0.84
2009 Noetzel MJ, Grant MK, El-Fakahany EE. Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding. Pharmacology. 83: 301-17. PMID 19401618 DOI: 10.1159/000214843  0.84
2009 Michal P, Rudajev V, El-Fakahany EE, Dolezal V. Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathways. European Journal of Pharmacology. 606: 50-60. PMID 19374848 DOI: 10.1016/j.ejphar.2009.01.028  0.84
2009 Noetzel MJ, Grant MK, El-Fakahany EE. Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor. Neurochemical Research. 34: 1138-49. PMID 19082883 DOI: 10.1007/s11064-008-9886-3  0.84
2008 Kane BE, Grant MK, El-Fakahany EE, Ferguson DM. Synthesis and evaluation of xanomeline analogs--probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor. Bioorganic & Medicinal Chemistry. 16: 1376-92. PMID 17977730 DOI: 10.1016/j.bmc.2007.10.058  0.84
2007 De Lorme KC, Grant MK, Noetzel MJ, Polson SB, El-Fakahany EE. Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex. The Journal of Pharmacology and Experimental Therapeutics. 323: 868-76. PMID 17855477 DOI: 10.1124/jpet.107.129940  0.84
2007 Machová E, Jakubík J, El-Fakahany EE, Doležal V. Wash-resistantly bound xanomeline inhibits acetylcholine release by persistent activation of presynaptic M2 and M4 muscarinic receptors in rat brain Journal of Pharmacology and Experimental Therapeutics. 322: 316-323. PMID 17446301 DOI: 10.1124/jpet.107.122093  0.84
2007 Michal P, El-Fakahany EE, Doležal V. Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins Journal of Pharmacology and Experimental Therapeutics. 320: 607-614. PMID 17065363 DOI: 10.1124/jpet.106.114314  0.84
2006 De Lorme KC, Sikorski KL, Grant MK, El-Fakahany EE. Long-term wash-resistant effects of brief interaction of xanomeline at the M1 muscarinic receptor. Neuroscience Letters. 410: 11-4. PMID 17052840 DOI: 10.1016/j.neulet.2006.09.062  0.84
2006 Jakubík J, El-Fakahany EE, Dolezal V. Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors. Molecular Pharmacology. 70: 656-66. PMID 16675658 DOI: 10.1124/mol.106.023762  0.84
2005 Grant MK, El-Fakahany EE. Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor. The Journal of Pharmacology and Experimental Therapeutics. 315: 313-9. PMID 16002459 DOI: 10.1124/jpet.105.090134  0.84
2005 Cuadra AE, El-Fakahany EE. Mechanisms of M(1) muscarinic receptor-mediated up-regulation of neuronal nitric oxide synthase in N1E-115 neuroblastoma cells. Brain Research. Molecular Brain Research. 134: 198-204. PMID 15836917 DOI: 10.1016/j.molbrainres.2004.10.022  0.84
2004 Grant MK, El-Fakahany EE. Therapeutic interventions targeting the nitric oxide system: current and potential uses in obstetrics, bone disease and erectile dysfunction. Life Sciences. 74: 1701-21. PMID 14741730 DOI: 10.1016/j.lfs.2003.08.029  0.84
2004 Jakubík J, Tucek S, El-Fakahany EE. Role of receptor protein and membrane lipids in xanomeline wash-resistant binding to muscarinic M1 receptors. The Journal of Pharmacology and Experimental Therapeutics. 308: 105-10. PMID 14569060 DOI: 10.1124/jpet.103.058594  0.84
2002 Linden DR, el-Fakahany EE. Arachidonic acid inhibition of muscarinic receptor-mediated nitric oxide production occurs at the level of calcium mobilization in Chinese hamster ovary cells. Neurochemical Research. 27: 441-9. PMID 12199147 DOI: 10.1023/A:1019892700049  0.84
2002 Grant MK, Cuadra AE, El-Fakahany EE. Endogenous expression of nNOS protein in several neuronal cell lines. Life Sciences. 71: 813-7. PMID 12074940 DOI: 10.1016/S0024-3205(02)01732-0  0.84
2002 Jakubík J, Tucek S, El-Fakahany EE. Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor. The Journal of Pharmacology and Experimental Therapeutics. 301: 1033-41. PMID 12023535 DOI: 10.1124/jpet.301.3.1033  0.84
2002 Linden DR, El-Fakahany EE. Microglial derived nitric oxide decreases serotonin content in rat basophilic leukemia (RBL-2H3) cells. European Journal of Pharmacology. 436: 53-6. PMID 11834246 DOI: 10.1016/S0014-2999(01)01615-6  0.84
2002 Iskender E, Cabadak H, Akici A, Zafer Gören M, Karaalp A, Ulusoy NB, Kan B, El-Fakahany EE, Oktay S. Carbachol induces nitric oxide generation in guinea-pig gallbladder Marmara Medical Journal. 15: 7-14.  0.84
2001 Christopoulos A, Grant MKO, Ayoubzadeh N, Kim ON, Sauerberg P, Jeppesen L, El-Fakahany EE. Synthesis and pharmacological evaluation of dimeric muscarinic acetylcholine receptor agonists Journal of Pharmacology and Experimental Therapeutics. 298: 1260-1268. PMID 11504829  0.84
2001 Wu HH, Selski DJ, El-Fakahany EE, McLoon SC. The role of nitric oxide in development of topographic precision in the retinotectal projection of chick. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 4318-25. PMID 11404417  0.84
2000 Christopoulos A, Grant MKO, El-Fakahany EE. Transducer abstraction - A novel approach to the detection of partial agonist efficacy in radioligand binding studies Journal of Pharmacological and Toxicological Methods. 43: 55-67. PMID 11091130 DOI: 10.1016/S1056-8719(00)00078-2  0.84
2000 Waid DK, Chell M, El-Fakahany EE. M2 and M4 muscarinic receptor subtypes couple to activation of endothelial nitric oxide synthase Pharmacology. 61: 37-42. PMID 10895079  0.84
2000 Fatemi SH, Cuadra AE, El-Fakahany EE, Sidwell RW, Thuras P. Prenatal viral infection causes alterations in nNOS expression in developing mouse brains Neuroreport. 11: 1493-1496. PMID 10841364  0.84
2000 Linden DR, Chell MJ, El-Fakahany EE, Seybold VS. Neurokinin3 receptors couple to the activation of neuronal nitric-oxide synthase in stably transfected Chinese hamster ovary cells Journal of Pharmacology and Experimental Therapeutics. 293: 559-568. PMID 10773029  0.84
2000 Jakubík J, El-Fakahany EE, Tuček S. Evidence for a tandem two-site model of ligand binding to muscarinic acetylcholine receptors Journal of Biological Chemistry. 275: 18836-18844. PMID 10749854 DOI: 10.1074/jbc.M000112200  0.84
2000 Carriere JL, El-Fakahany EE. Choline is a full agonist in inducing activation of neuronal nitric oxide synthase via the muscarinic M1 receptor Pharmacology. 60: 82-89. PMID 10657757  0.84
2000 Akici A, Karaalp A, Iskender E, Christopoulos A, El-Fakahany EE, Oktay S. Further evidence for the heterogeneity of functional muscarinic receptors in guinea pig gallbladder European Journal of Pharmacology. 388: 115-123. PMID 10657554 DOI: 10.1016/S0014-2999(99)00832-8  0.84
1999 Christopoulos A, Parsons AM, Lew MJ, El-Fakahany EE. The assessment of antagonist potency under conditions of transient response kinetics European Journal of Pharmacology. 382: 217-227. PMID 10556673 DOI: 10.1016/S0014-2999(99)00550-6  0.84
1999 Akici A, Karaalp A, Iskender E, El-Fakahany EE, Oktay S. Muscarinic M2 receptors are not primarily involved in the contraction of guinea-pig gallbladder smooth muscle Pharmacological Research. 40: 443-449. PMID 10527660 DOI: 10.1006/phrs.1999.0536  0.84
1999 Grant MKO, Christopoulos A, El-Fakahany EE. Regulation of acetylcholine binding by ATP at the muscarinic M1 receptor in intact CHO cells Brain Research. 839: 94-99. PMID 10482803 DOI: 10.1016/S0006-8993(99)01720-5  0.84
1999 Christopoulos A, El-Fakahany EE. Qualitative and quantitative assessment of relative agonist efficacy Biochemical Pharmacology. 58: 735-748. PMID 10449182 DOI: 10.1016/S0006-2952(99)00087-8  0.84
1999 Michal P, Lysíková M, El-Fakahany EE, Tuček S. Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors European Journal of Pharmacology. 376: 119-125. PMID 10440097 DOI: 10.1016/S0014-2999(99)00341-6  0.84
1999 Christopoulos A, Parsons AM, El-Fakahany EE. Pharmacological analysis of the novel mode of interaction between xanomeline and the M1 muscarinic acetylcholine receptor Journal of Pharmacology and Experimental Therapeutics. 289: 1220-1228. PMID 10336509  0.84
1999 Parsons AM, Sorman JL, El-Fakahany EE. Regulation of M1 muscarinic receptor-mediated signaling in intact cells by exogenous, but not endogenously produced, nitric oxide Neurochemical Research. 24: 85-94. PMID 9973241 DOI: 10.1023/A:1020936231662  0.84
1999 Christopoulos A, Sorman JL, Mitchelson F, El-Fakahany EE. Characterization of the subtype selectivity of the allosteric modulator heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl) ammonium bromide (c7/3-phth) at cloned muscarinic acetylcholine receptors Biochemical Pharmacology. 57: 171-179. PMID 9890565 DOI: 10.1016/S0006-2952(98)00277-9  0.84
1999 Ernst AF, Wu HH, El-Fakahany EE, McLoon SC. NMDA receptor-mediated refinement of a transient retinotectal projection during development requires nitric oxide. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 229-35. PMID 9870953  0.84
1998 Christopoulos A, El-Fakahany EE. Minireview: The generation of nitric oxide by G protein-coupled receptors Life Sciences. 64: 1-15. PMID 10027737 DOI: 10.1016/S0024-3205(98)00348-8  0.84
1998 Tuček S, Jakubík J, Doležal V, El-Fakahany EE. Positive effects of allosteric modulators on the binding properties and the function of muscarinic acetylcholine receptors Journal of Physiology Paris. 92: 241-243. PMID 9789816 DOI: 10.1016/S0928-4257(98)80026-0  0.84
1998 Oktay S, Cabadak H, Iskender E, Gören Z, CaliÅŸkan E, Orun O, Aslan N, Karaalp A, Tolun A, Ulusoy NB, Levey AI, El-Fakahany EE, Kan B. Evidence for the presence of muscarinic M2 and M4 receptors in guinea-pig gallbladder smooth muscle. Journal of Autonomic Pharmacology. 18: 195-204. PMID 9788289 DOI: 10.1046/j.1365-2680.1998.18474.x  0.84
1998 Cuadra AE, El-Fakahany EE. Up-regulation of the neuronal form of nitric oxide synthase in response to prolonged muscarinic M1 receptor stimulation Journal of Neurochemistry. 71: 571-579. PMID 9681447  0.84
1998 Wotta DR, Parsons AM, Hu J, Grande AW, El-Fakahany EE. M1 muscarinic receptors stimulate rapid and prolonged phases of neuronal nitric oxide synthase activity: Involvement of different calcium pools Journal of Neurochemistry. 71: 487-497. PMID 9681438  0.84
1998 Christopoulos A, Pierce TL, Sorman JL, El-Fakahany EE. On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor Molecular Pharmacology. 53: 1120-1130. PMID 9614217  0.84
1998 Wotta DR, Wattenberg EV, Langason RB, El-Fakahany EE. M1, M3 and M5 muscarinic receptors stimulate mitogen-activated protein kinase Pharmacology. 56: 175-186. PMID 9566019 DOI: 10.1159/000028196  0.84
1997 Christopoulos A, El-Fakahany EE. Novel persistent activation of muscarinic M1 receptors by xanomeline European Journal of Pharmacology. 334: R3-R4. PMID 9346340 DOI: 10.1016/S0014-2999(97)01162-X  0.84
1997 Cuadra AE, El-Fakahany EE. Enhancement of maximal activation of neuronal nitric oxide synthase at muscarinic M1 receptors following prolonged agonist treatment European Journal of Pharmacology. 334: 107-110. PMID 9346336 DOI: 10.1016/S0014-2999(97)01164-3  0.84
1997 Wang SZ, Lee SY, Zhu SZ, Wotta DR, Parsons AM, el-Fakahany EE. Activation of neuronal nitric oxide synthase by M2 muscarinic receptors associated with a small increase in intracellular calcium. Pharmacology. 55: 10-7. PMID 9309796  0.84
1997 Jakubík J, Bačáková L, El-Fakahany EE, Tuček S. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors Molecular Pharmacology. 52: 172-179. PMID 9224827  0.84
1997 Wotta DR, El-Fakahany EE. Muscarinic receptor-mediated activation of nitric oxide synthase Drug Development Research. 40: 205-214. DOI: 10.1002/(SICI)1098-2299(199702)40:2<205::AID-DDR10>3.0.CO;2-K  0.84
1996 Wang SZ, Lee SY, Zhu SZ, el-Fakahany EE. Differential coupling of m1, m3, and m5 muscarinic receptors to activation of neuronal nitric oxide synthase. Pharmacology. 53: 271-80. PMID 8990485  0.84
1996 Lee SY, Zhu SZ, el-Fakahany EE. Role of two highly conserved tyrosine residues in the m1 muscarinic receptor second transmembrane domain in ligand binding and receptor function Receptors & Signal Transduction. 6: 43-52. PMID 8933621  0.84
1996 Hu J, El-Fakahany EE. Intricate regulation of nitric oxide synthesis in neurons Cellular Signalling. 8: 185-189. PMID 8736702 DOI: 10.1016/0898-6568(95)02053-5  0.84
1996 Wang SZ, Edmundson R, Zhu SZ, El-Fakahany EE. Selective enhancement of antagonist ligand binding at muscarinic M2 receptors by heparin due to receptor uncoupling European Journal of Pharmacology. 296: 113-118. PMID 8720484 DOI: 10.1016/0014-2999(95)00674-5  0.84
1996 Jakubík J, Bačáková L, Lisá V, El-Fakahany EE, Tuček S. Activation of muscarinic acetylcholine receptors via their allosteric binding sites Proceedings of the National Academy of Sciences of the United States of America. 93: 8705-8709. PMID 8710935 DOI: 10.1073/pnas.93.16.8705  0.84
1995 Hejnová L, Tuček S, El-Fakahany EE. Positive and negative allosteric interactions on muscarinic receptors European Journal of Pharmacology: Molecular Pharmacology. 291: 427-430. PMID 8719429 DOI: 10.1016/0922-4106(95)90085-3  0.84
1995 Zhu SZ, Lee SY, Wang SZ, el-Fakahany EE. Investigation of the role of an amino acid triplet repeat in differentiating drug-receptor interaction at m1 and m2 muscarinic receptors. Pharmacology. 51: 298-307. PMID 8584581 DOI: 10.1159/000139339  0.84
1995 Parsons AM, El-Fakahany EE, Seybold VS. Tachykinins alter inositol phosphate formation, but not cyclic AMP levels, in primary cultures of neonatal rat spinal neurons through activation of neurokinin receptors Neuroscience. 68: 855-865. PMID 8577379 DOI: 10.1016/0306-4522(95)00140-E  0.84
1995 Jakubík J, Bačáková L, El-Fakahany EE, Tuček S. Constitutive activity of the M1-M4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists Febs Letters. 377: 275-279. PMID 8543067 DOI: 10.1016/0014-5793(95)01360-1  0.84
1995 Hu J, Wang SZ, Scapecchi S, Gualtieri F, El-Fakahany EE. Cardioselective derivatives of 2, 2-Diphenyl-2-ethylthioacetate do not discriminate between m2 and m3 muscarinic receptors expressed in CHO cells Pharmacology. 50: 273-285. PMID 7667389 DOI: 10.1159/000139293  0.84
1995 Jakubik J, Bacakova L, El-Fakahany EE, Tucek S. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors Journal of Pharmacology and Experimental Therapeutics. 274: 1077-1083. PMID 7562472  0.84
1995 Hu J, Fridlund J, El-Fakahany EE. Regulation of neuronal nitric oxide synthase by histone, protamine, and myelin basic protein Neurochemical Research. 20: 497-503. PMID 7544448 DOI: 10.1007/BF00973107  0.84
1995 Hu J, El-Fakahany EE. Anomalous increase in nitric oxide synthase activity by certain nitric oxide-generating compounds in intact neuronal cells Journal of Neurochemistry. 65: 117-124. PMID 7540659  0.84
1995 Iadecola C, Xu X, Zhang F, El-Fakahany EE, Ross ME. Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia Journal of Cerebral Blood Flow and Metabolism. 15: 52-59. PMID 7528224  0.84
1995 Shou Zhen Wang, Sheng Zu Zhu, El-Fakahany EE. Expression of endogenous muscarinic acetylcholine receptors in Chinese hamster ovary cells European Journal of Pharmacology: Molecular Pharmacology. 291: R1-R2. DOI: 10.1016/0922-4106(95)90148-5  0.84
1995 Lee SY, Kim ON, El-Fakahany EE. Inhibition of neuronal nitric oxide synthase by antidepressants Pharmacology Communications. 7: 1-9.  0.84
1994 Zhu SZ, Wang SZ, Hu J, El-Fakahany EE. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor Molecular Pharmacology. 45: 517-523. PMID 8145736  0.84
1994 Hu J, El-Fakahany EE. An artifact associated with using trypan blue exclusion to measure effects of amyloid β on neuron viability Life Sciences. 55: 1009-1016. PMID 8084205 DOI: 10.1016/0024-3205(94)00635-0  0.84
1994 Hu J, Lee JH, El-Fakahany EE. Inhibition of neuronal nitric oxide synthase by antipsychotic drugs Psychopharmacology. 114: 161-166. PMID 7531351 DOI: 10.1007/BF02245458  0.84
1994 Hu J, Mahmoud MI, El-Fakahany EE. Polyamines inhibit nitric oxide synthase in rat cerebellum Neuroscience Letters. 175: 41-45. PMID 7526294 DOI: 10.1016/0304-3940(94)91073-1  0.84
1994 Iadecola C, Xu X, Fangyi Zhang, Hu J, El-Fakahany EE. Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-l-arginine methyl ester Neurochemical Research. 19: 501-505. PMID 7520540 DOI: 10.1007/BF00967330  0.84
1994 Shou Zhen Wang, Sheng Zu Zhu, El-Fakahany EE. Efficient coupling of m5 muscarinic acetylcholine receptors to activation of nitric oxide synthase Journal of Pharmacology and Experimental Therapeutics. 268: 552-557. PMID 7509388  0.84
1994 Lee JH, El-Fakahany EE. Screening test(I) of several antipsychotic agents on NO formation Korean Journal of Pharmacology. 30: 343-349.  0.84
1993 Kiefer-Day J, Abdallah ESAM, Forray C, Lee NH, Kim ON, El-Fakahany EE. Effects of tacrine on brain muscarinic-receptor-mediated second-messenger signals Pharmacology. 47: 98-110. PMID 8395061 DOI: 10.1159/000139084  0.84
1993 Hu J, El-Fakahany EE. Role of intercellular and intracellular communication by nitric oxide in coupling of muscarinic receptors to activation of guanylate cyclase in neuronal cells Journal of Neurochemistry. 61: 578-585. PMID 8101558  0.84
1993 Hu J, El-Fakahany EE. β-amyloid 25-35 activates nitric oxide synthase in a neuronal clone Neuroreport. 4: 760-762. PMID 7688591  0.84
1993 Wang SZ, El-Fakahany EE. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists Journal of Pharmacology and Experimental Therapeutics. 266: 237-243. PMID 7687290  0.84
1993 Hu J, El-Fakahany EE. Allosteric interaction of dynorphin and myelin basic protein with muscarinic receptors Pharmacology. 47: 351-359. PMID 7506424  0.84
1992 Lee NH, Hu J, El-Fakahany EE. Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor Journal of Pharmacology and Experimental Therapeutics. 262: 312-316. PMID 1625205  0.84
1992 Hu J, Wang SZ, Forray C, El-Fakahany EE. Complex allosteric modulation of cardiac muscarinic receptors by protamine: Potential model for putative endogenous ligands Molecular Pharmacology. 42: 311-321. PMID 1513329  0.84
1992 Wang SZ, Zhu SZ, Joseph JA, el-Fakahany EE. Comparison of the level of mRNA encoding m1 and m2 muscarinic receptors in brains of young and aged rats. Neuroscience Letters. 145: 149-52. PMID 1465211 DOI: 10.1016/0304-3940(92)90008-U  0.84
1992 Wang SZ, Zhu SZ, Mash DC, El-Fakahany EE. Comparison of the concentration of messenger RNA encoding four muscarinic receptor subtypes in control and Alzheimer brains Molecular Brain Research. 16: 64-70. PMID 1334201 DOI: 10.1016/0169-328X(92)90194-G  0.84
1992 Mohamed AS, Forray C, Aly MH, el-Fakahany EE. Lack of intrinsic activity and significant subtype selectivity of SR 95639A at muscarinic receptors. European Journal of Pharmacology. 227: 181-7. PMID 1330650 DOI: 10.1016/0922-4106(92)90126-G  0.84
1992 Kiefer-Day JS, El-Fakahany EE. Muscarinic receptor function and acetylcholinesterase activity after chronic administration of tacrine to mice at therapeutic drug concentrations Pharmacology. 44: 71-80. PMID 1315062 DOI: 10.1159/000138875  0.84
1991 Zhu SZ, Wang SZ, Abdallah EAM, El-Fakahany EE. DFP-induced regulation of cardiac muscarinic receptor mRNA in vivo measured by DNA-excess solution hybridization Life Sciences. 48: 2579-2584. PMID 2046480 DOI: 10.1016/0024-3205(91)90615-I  0.84
1991 Lee NH, El-Fakahany EE. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes Journal of Pharmacology and Experimental Therapeutics. 256: 468-479. PMID 1993991  0.84
1991 Lee NH, El-Fakahany EE. Allosteric antagonists of the muscarinic acetylcholine receptor Biochemical Pharmacology. 42: 199-205. PMID 1859442 DOI: 10.1016/0006-2952(91)90703-8  0.84
1991 Kiefer-Day JS, Campbell HE, Towles J, El-Fakahany EE. Muscarinic subtype selectivity of tetrahydroaminoacridine: Possible relationship to its capricious efficacy European Journal of Pharmacology. 203: 421-423. PMID 1773827 DOI: 10.1016/0014-2999(91)90901-2  0.84
1991 Fernando JCR, Abdallah ESAM, Evinger M, Forray C, El-Fakahany EE. The presence of an M4 subtype muscarinic receptor in the bovine adrenal medulla revealed by mRNA and receptor binding analyses European Journal of Pharmacology: Molecular Pharmacology. 207: 297-303. PMID 1723686 DOI: 10.1016/0922-4106(91)90003-Z  0.84
1991 Hu J, Wang SZ, El-Fakahany EE. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells Journal of Pharmacology and Experimental Therapeutics. 257: 938-945. PMID 1710663  0.84
1991 Pou S, Pou WS, Rosen GM, El-Fakahany EE. N-Hydroxylamine is not an intermediate in the conversion of L-arginine to an activator of soluble guanylate cyclase in neuroblastoma N1E-115 cells Biochemical Journal. 273: 547-552. PMID 1671745  0.84
1991 Abdallah EA, el-Fakahany EE. Lack of desensitization of muscarinic receptor-mediated second messenger signals in rat brain upon acute and chronic inhibition of acetylcholinesterase Journal of Biochemical Toxicology. 6: 261-268. PMID 1663554  0.84
1991 Jett DA, Abdallah EAM, El-Fakahany EE, Eldefrawi ME, Eldefrawi AT. High-affinity activation by paraoxon of a muscarinic receptor subtype in rat brain striatum Pesticide Biochemistry and Physiology. 39: 149-157. DOI: 10.1016/0048-3575(91)90135-9  0.84
1990 Fryer AD, El-Fakahany EE. Identification of three muscarinic receptor subtypes in rat lung using binding studies with selective antagonists Life Sciences. 47: 611-618. PMID 2402185 DOI: 10.1016/0024-3205(90)90572-9  0.84
1990 Lee NH, El-Fakahany EE. The allosteric binding profile of himbacine: a comparison with other cardioselective muscarinic antagonists European Journal of Pharmacology. 179: 225-229. PMID 2364985 DOI: 10.1016/0014-2999(90)90424-5  0.84
1990 Wang SZ, Hu J, Long RM, Pou WS, Forray C, El-Fakahany EE. Agonist-induced down-regulation of m1 muscarinic receptors and reduction of their mRNA level in a transfected cell line Febs Letters. 276: 185-188. PMID 2265699 DOI: 10.1016/0014-5793(90)80538-T  0.84
1990 Fryer AD, El-Fakahany EE, Jacoby DB. Parainfluenza virus type 1 reduces the affinity of agonists for muscarinic receptors in guinea-pig lung and heart European Journal of Pharmacology. 181: 51-58. PMID 2167230 DOI: 10.1016/0014-2999(90)90244-Z  0.84
1990 Abdallah EAM, Forray C, El-Fakahany EE. Relationship between the partial inhibition of muscarinic receptor-mediated phosphoinositide hydrolysis by phorbol esters and tetrodotoxin in rat cerebral cortex Molecular Brain Research. 8: 1-7. PMID 2166196 DOI: 10.1016/0169-328X(90)90002-U  0.84
1990 Forray C, El-Fakahany EE. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex Molecular Pharmacology. 37: 893-902. PMID 2163015  0.84
1990 Lai WS, Rogers TB, el-Fakahany EE. Protein kinase C is involved in desensitization of muscarinic receptors induced by phorbol esters but not by receptor agonists. The Biochemical Journal. 267: 23-9. PMID 2158308  0.84
1990 Lai WS, el-Fakahany EE. Antagonism by the diacylglycerol kinase inhibitor R59 022 of muscarinic receptor-mediated cyclic GMP formation and binding of [3H]N-methylscopolamine. Biochemical Pharmacology. 39: 221-2. PMID 2153379 DOI: 10.1016/0006-2952(90)90671-7  0.84
1990 el-Fakahany EE, Cioffi CL. Molecular mechanisms of regulation of neuronal muscarinic receptor sensitivity. Membrane Biochemistry. 9: 9-27. PMID 2077364 DOI: 10.3109/09687689009026820  0.84
1990 Pou WS, Pou S, Rosen GM, El-Fakahany EE. EDRF release is a common pathway in the activation of guanylate cyclase by receptor agonists and calcium ionophores European Journal of Pharmacology. 182: 393-394. PMID 1975786 DOI: 10.1016/0014-2999(90)90300-U  0.84
1990 Arroyo CM, Forray C, El-Fakahany EE, Rosen GM. Receptor-mediated generation of an EDRF-like intermediate in a neuronal cell line detected by spin trapping techniques Biochemical and Biophysical Research Communications. 170: 1177-1183. PMID 1975169 DOI: 10.1016/0006-291X(90)90517-Q  0.84
1990 Surichamorn W, Forray C, El-Fakahany EE. Role of intracellular Ca2+ mobilization in muscarinic and histamine receptor-mediated activation of guanylate cyclase in N1E-115 neuroblastoma cells: Assessment of the arachidonic acid release hypothesis Molecular Pharmacology. 37: 860-869. PMID 1972774  0.84
1990 Meng Y, Hu J, El-Fakahany EE. p-fluoro-hexahydro-sila-difenidol exhibits poor selectivity between m3 and m1 muscarinic receptors Molecular Membrane Biology. 9: 293-300. PMID 1967074 DOI: 10.3109/09687689009025848  0.84
1990 Abdallah EAM, Pou WS, El-Fakahany EE. Aging does not alter muscarinic receptor-mediated inhibition of cyclic AMP formation in the striatum and hippocampus Brain Research. 534: 234-236. PMID 1963561 DOI: 10.1016/0006-8993(90)90133-V  0.84
1990 Silverman HJ, Lee NH, el-Fakahany EE. Effects of canine endotoxin shock on lymphocytic beta-adrenergic receptors. Circulatory Shock. 32: 293-306. PMID 1963122  0.84
1990 Hu J, El-Fakahany EE. Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors Molecular Pharmacology. 38: 895-903. PMID 1701216  0.84
1989 Fryer AD, El-Fakahany EE. An endogenous factor induces heterogeneity of binding sites of selective muscarinic receptor antagonists in rat heart Molecular Membrane Biology. 8: 127-132. PMID 2641948 DOI: 10.3109/09687688909025826  0.84
1989 Lee NH, Fryer AD, Forray C, El-Fakahany EE. Different mechanisms of antagonism by methoctramine of two neuronal muscarinic receptor-mediated second messenger responses Journal of Pharmacology and Experimental Therapeutics. 251: 992-999. PMID 2557423  0.84
1989 Lee NH, Forray C, El-Fakahany EE. Methoctramine, a cardioselective muscarinic antagonist, stimulates phosphoinositide hydrolysis in rat cerebral cortex European Journal of Pharmacology. 167: 295-298. PMID 2556288 DOI: 10.1016/0014-2999(89)90591-8  0.84
1989 Surichamorn W, Abdallah EAM, El-Fakahany EE. Aging does not alter brain muscarinic receptor-mediated phosphoinositide hydrolysis and its inhibition by phorbol esters, tetrodotoxin and receptor desensitization Journal of Pharmacology and Experimental Therapeutics. 251: 543-549. PMID 2553927  0.84
1989 Lee NH, El-Fakahany EE. Mixed competitive and allosteric antagonism by gallamine of muscarinic receptor-mediated second messenger responses in N1E-115 neuroblastoma cells Journal of Neurochemistry. 53: 1300-1308. PMID 2549200  0.84
1989 Surichamorn W, Amrhein CL, Forray C, El-Fakahany EE. Inhibition of cyclic AMP formation in N1E-115 neuroblastoma cells is mediated by a non-cardiac M2 muscarinic receptor subtype Brain Research. 493: 320-325. PMID 2548669 DOI: 10.1016/0006-8993(89)91166-9  0.84
1989 McKinney M, Anderson D, Forray C, El-Fakahany EE. Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: A comparison with the brainstem M2 receptor Journal of Pharmacology and Experimental Therapeutics. 250: 565-572. PMID 2547939  0.84
1989 Cioffi CL, el-Fakahany EE. Differential sensitivity of phosphoinositide and cyclic GMP responses to short-term regulation by a muscarinic agonist in mouse neuroblastoma cells. Correlation with down-regulation of cell surface receptors. Biochemical Pharmacology. 38: 1827-34. PMID 2544180 DOI: 10.1016/0006-2952(89)90418-8  0.84
1988 Lai WS, el-Fakahany EE. Regulation of [3H]phorbol-12,13-dibutyrate binding sites in mouse neuroblastoma cells: simultaneous down-regulation by phorbol esters and desensitization of their inhibition of muscarinic receptor function. The Journal of Pharmacology and Experimental Therapeutics. 244: 41-50. PMID 3422096  0.84
1988 Lee NH, El-Fakahany EE. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions Journal of Pharmacology and Experimental Therapeutics. 246: 829-838. PMID 3418516  0.84
1988 Surichamorn W, Kim ON, Lee NH, Lai WS, el-Fakahany EE. Effects of aging on the interaction of quinuclidinyl benzilate, N-methylscopolamine, pirenzepine, and gallamine with brain muscarinic receptors. Neurochemical Research. 13: 1183-91. PMID 3237310 DOI: 10.1007/BF00971637  0.84
1988 McKinney M, Lee NH, Anderson DJ, Vella-Rountree L, El-Fakahany EE. Non-selectivity of amitriptyline for subtypes of brain muscarinic receptors demonstrated in binding and functional assays European Journal of Pharmacology. 157: 51-60. PMID 2853074 DOI: 10.1016/0014-2999(88)90470-0  0.84
1988 Cioffi CL, el-Fakahany EE. Lack of alterations in muscarinic receptor subtypes and phosphoinositide hydrolysis upon acute DFP treatment. European Journal of Pharmacology. 156: 35-45. PMID 2850209 DOI: 10.1016/0014-2999(88)90144-6  0.84
1988 el-Fakahany EE, Surichamorn W, Amrhein CL, Stenstrom S, Cioffi CL, Richelson E, McKinney M. Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine. The Journal of Pharmacology and Experimental Therapeutics. 247: 934-40. PMID 2849677  0.84
1988 Mattia A, Marquis KL, Leccesse AP, El-Fakahany EE, Moreton JE. Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat Journal of Pharmacology and Experimental Therapeutics. 246: 797-802. PMID 2841454  0.84
1988 el-Fakahany EE, Alger BE, Lai WS, Pitler TA, Worley PF, Baraban JM. Neuronal muscarinic responses: role of protein kinase C. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 2: 2575-83. PMID 2838363  0.84
1988 Ramkumar V, El-Fakahany EE. Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence European Journal of Pharmacology. 146: 73-83. PMID 2832198 DOI: 10.1016/0014-2999(88)90488-8  0.84
1988 Ramkumar V, El-Fakahany EE. Morphine treatment increases [3H]nimodipine binding sites in rat brain. Attenuation by nimodipine and other Ca2+ channel antagonists of naloxone-precipitated withdrawal in morphine-dependent animals Annals of the New York Academy of Sciences. 522: 207-209.  0.84
1987 Lai WS, el-Fakahany EE. Phorbol ester-induced inhibition of cyclic GMP formation mediated by muscarinic receptors in murine neuroblastoma cells. The Journal of Pharmacology and Experimental Therapeutics. 241: 366-73. PMID 3033212  0.84
1987 Lee JH, El-Fakahany EE. Agonist-induced desensitization of muscarinic acetylcholine receptor in rat brain Archives of Pharmacal Research. 10: 212-218. DOI: 10.1007/BF02857742  0.84
1987 Jong-Hwa Lee, El-Fakahany EE. Multiple binding affinities for muscarinic acetylcholine receptors in rat brain Korean Journal of Pharmacology. 23: 101-111.  0.84
1986 Cioffi CL, el-Fakahany EE. Decreased binding of the muscarinic antagonist [3H]N-methylscopolamine in mouse brain following acute treatment with an organophosphate. European Journal of Pharmacology. 132: 147-54. PMID 3816972 DOI: 10.1016/0014-2999(86)90599-6  0.84
1986 El-Fakahany EE, Lee JH. Agonist-induced muscarinic acetylcholine receptor down-regulation in intact rat brain cells European Journal of Pharmacology. 132: 21-30. PMID 3816962 DOI: 10.1016/0014-2999(86)90004-X  0.84
1986 el-Fakahany EE, Cioffi CL, Abdellatif MM, Miller MM. Competitive interaction of pirenzepine with rat brain muscarinic acetylcholine receptors. European Journal of Pharmacology. 131: 237-47. PMID 3816954 DOI: 10.1016/0014-2999(86)90577-7  0.84
1986 Lai WS, el-Fakahany EE. A selective effect of protein kinase C activation on pirenzepine high-affinity muscarinic receptors in a neuronal clone. European Journal of Pharmacology. 129: 201-2. PMID 3770074 DOI: 10.1016/0014-2999(86)90356-0  0.84
1986 el-Fakahany EE, Ramkumar V, Lai WS. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 238: 554-63. PMID 3755473  0.84
1986 Cioffi CL, el-Fakahany EE. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites. The Journal of Pharmacology and Experimental Therapeutics. 238: 916-23. PMID 3018226  0.84
1986 Rogers NF, el-Fakahany E. Morphine-induced opioid receptor down-regulation detected in intact adult rat brain cells. European Journal of Pharmacology. 124: 221-30. PMID 3015639 DOI: 10.1016/0014-2999(86)90223-2  0.84
1986 Mattia A, El-Fakahany EE, Moreton JE. Behavioral and receptor binding studies of phencyclidine (PCP) and lithium interaction in the rat Life Sciences. 38: 975-984. PMID 3005791 DOI: 10.1016/0024-3205(86)90230-4  0.84
1986 Lai WS, el-Fakahany EE. Interaction of 4-aminopyridine with [3H]phencyclidine receptors in rat brain homogenates. Neuroscience Letters. 67: 87-91. PMID 2425297 DOI: 10.1016/0304-3940(86)90214-4  0.84
1986 Ramkumar V, El-Fakahany EE. The current status of the dihydropyridine calcium channel antagonist binding sites in the brain Trends in Pharmacological Sciences. 7: 171-172. DOI: 10.1016/0165-6147(86)90303-2  0.84
1985 Lee JH, El-Fakahany EE. [3H]N-methylscopolamine binding to muscarinic receptors in intact adult rat brain cell aggregates Biochemical Pharmacology. 34: 4299-4303. PMID 4074390 DOI: 10.1016/0006-2952(85)90288-6  0.84
1985 Ramkumar V, El-Fakahany EE. Changes in the affinity of [3H]nimodipine binding sites in the brain upon chlorpromazine treatment and subsequent withdrawal Research Communications in Chemical Pathology and Pharmacology. 48: 463-466. PMID 4040645  0.84
1985 Lee JH, El-Fakahany EE. Use of intact rat brain cells as a model to study regulation of muscarinic acetylcholine receptors Life Sciences. 37: 515-521. PMID 4021726 DOI: 10.1016/0024-3205(85)90463-1  0.84
1985 Lee JH, El-Fakahany EE. Anomalous binding of [3H]N-methylscopolamine to rat brain muscarinic receptors European Journal of Pharmacology. 110: 263-266. PMID 3987816 DOI: 10.1016/0014-2999(85)90221-3  0.84
1985 Feigenbaum P, El-Fakahany EE. Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: Possible involvement in desensitization of receptor function Journal of Pharmacology and Experimental Therapeutics. 233: 134-140. PMID 3981451  0.84
1985 Lee JH, El-Fakahany EE. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates Journal of Pharmacology and Experimental Therapeutics. 233: 707-714. PMID 3839264  0.84
1985 Rogers NF, el-Fakahany EE. Intact brain cells: a novel model system for studying opioid receptor binding. Life Sciences. 37: 307-14. PMID 2989648 DOI: 10.1016/0024-3205(85)90500-4  0.84
1985 Khazan N, Young GA, El-Fakahany EE, Hong O, Calligaro D. Sigma opioid receptor; SKF-10,047 update Neuropeptides. 5: 339-340. PMID 2987734 DOI: 10.1016/0143-4179(85)90022-8  0.84
1985 Lai WS, Ramkumar V, el-Fakahany EE. Possible allosteric interaction of 4-aminopyridine with rat brain muscarinic acetylcholine receptors. Journal of Neurochemistry. 44: 1936-42. PMID 2580955  0.84
1985 El-Fakahany EE. Additional complexities in the binding of muscarinic receptor antagonists Trends in Pharmacological Sciences. 6: 430-431. DOI: 10.1016/0165-6147(85)90204-4  0.84
1985 Rogers NF, El-Fakahany EE. Opioid receptor binding to intact brain cells Federation Proceedings. 44: No. 1165.  0.84
1984 Feigenbaum P, El-Fakahany EE. Short-term regulation of muscarinic acetylcholine receptor binding in cultured nerve cells Research Communications in Chemical Pathology and Pharmacology. 43: 519-522. PMID 6718813  0.84
1984 El-Fakahany EE, Eldefrawi AT, Murphy DL, Aguayo LG, Triggle DJ, Albuquerque EX, Eldefrawi ME. Interactions of phencyclidine with crayfish muscle membranes. Sensitivity to calcium channel antagonists and other drugs. Molecular Pharmacology. 25: 369-78. PMID 6328263  0.84
1984 El-Fakahany EE, Triggle DJ, Eldefrawi AT, Eldefrawi ME. Distinction between high-affinity [3H]phencyclidine binding sites and muscarinic receptors in guinea-pig ileum muscle. The Journal of Pharmacology and Experimental Therapeutics. 229: 447-54. PMID 6325665  0.84
1984 El-Fakahany EE, Pfenning M, Richelson E. Kinetic effects of terbium ions on muscarinic acetylcholine receptors of murine neuroblastoma cells Journal of Neurochemistry. 42: 863-869. PMID 6319610  0.84
1984 Ramkumar V, El-Fakahany EE. Increase in [3H]nitrendipine binding sites in the brain in morphine-tolerant mice European Journal of Pharmacology. 102: 371-372. PMID 6090166 DOI: 10.1016/0014-2999(84)90272-3  0.84
1984 Feigenbaum P, El-Fakahany EE. Short-term regulation of muscarinic acetylcholine receptor density in cultured nerve cells Federation Proceedings. 43: no. 3426.  0.84
1984 Ramkumar V, El-Fakahany EE, Roffman DS. The effect of intermittent dobutamine infusion on beta-adrenergic receptors in human lymphocytes Federation Proceedings. 43: no. 412.  0.84
1984 Rogers NP, Hong O, El-Fakahany EE. Ethylketocyclazocide interaction with the MU opioid receptor Federation Proceedings. 43: no. 2377.  0.84
1982 Richelson E, El-Fakahany E. Changes in the sensitivity of receptors for neurotransmitters and the actions of some psychotherapeutic drugs Mayo Clinic Proceedings. 57: 576-582. PMID 6125630  0.84
1981 El-Fakahany E, Richelson E. Phenoxybenzamine and dibenamine interactions with calcium channel effectors of the muscarinic receptor Molecular Pharmacology. 20: 519-525. PMID 6276712  0.84
1981 Richelso E, El-Fakahany E. The molecular basis of neurotransmission at the muscarinic receptor Biochemical Pharmacology. 30: 2887-2891. PMID 6274353 DOI: 10.1016/0006-2952(81)90248-3  0.84
1981 El-Fakahany E, Richelson E. Effects of lanthanides on muscarinic acetylcholine receptor function Molecular Pharmacology. 19: 282-290. PMID 6262619  0.84
1980 Ismail M, Ghazal A, El-Fakahany EE. Cardiovascular effects of venom from the scorpion Buthus occitanus, Amoreux Toxicon. 18: 327-337. PMID 7394821 DOI: 10.1016/0041-0101(80)90013-6  0.84
1980 El-Fakahany E, Richelson E. Involvement of calcium channels in short-term desensitization of muscarinic receptor-mediated cyclic GMP formation in mouse neuroblastoma cells Proceedings of the National Academy of Sciences of the United States of America. 77: 6897-6901. PMID 6256769  0.84
1980 El-Fakahany E, Richelson E. Temperature dependence of muscarinic acetylcholine receptor activation, desensitization, and resensitization Journal of Neurochemistry. 34: 1288-1295. PMID 6246206  0.84
1980 El-Fakahany E, Richelson E. Regulation of muscarinic receptor-mediated cyclic GMP synthesis by cultured mouse neuroblastoma cells Journal of Neurochemistry. 35: 941-948. PMID 6109003  0.84
1979 Taylor JE, El-Fakahany E, Richelson E. Long-term regulation of muscarinic acetylcholine receptors on cultured nerve cells Life Sciences. 25: 2181-2187. PMID 232208 DOI: 10.1016/0024-3205(79)90090-0  0.84
Show low-probability matches.